Neoadjuvant Endobiliary Photodynamic Therapy in Klatskin Tumor Patients before Resection. First Experience
https://doi.org/10.37174/2587-7593-2022-5-3-70-77
Abstract
Complete liver and bile ducts resection with negative margins (R0) in the only possible radical treatment of Klatskin tumor. Even after R0 resection, the recurrence rate is as high as 50–76 %. Neoadjuvant endobiliary photodynamic therapy (PDT) may potentially improve their results and longterm survival. The authors present their own first experience of endobiliary PDT performing before liver and bile ducts resection (R0) in Klatskin tumor patient.
About the Authors
D. Yu. FrantsevRussian Federation
115478
24 Kashirskoye Highway
Moscow
E. R. Virshke
Russian Federation
115478
24 Kashirskoye Highway
Moscow
I. V. Pogrebnyakov
Russian Federation
115478
24 Kashirskoye Highway
Moscow
E. A. Nasonova
Russian Federation
115478
24 Kashirskoye Highway
Moscow
S. M. Abdulkarimova
Russian Federation
115478
24 Kashirskoye Highway
Moscow
A. N. Polyakov
Russian Federation
115478
24 Kashirskoye Highway
Moscow
D. V. Podluzhny
Russian Federation
115478
24 Kashirskoye Highway
Moscow
N. E. Kudashkin
Russian Federation
115478
24 Kashirskoye Highway
Moscow
E. A. Moroz
Russian Federation
115478
24 Kashirskoye Highway
Moscow
M. E. Timofeev
Russian Federation
115478
24 Kashirskoye Highway
Moscow
B. I. Dolgushin
Russian Federation
115478
24 Kashirskoye Highway
Moscow
References
1. Groot Koerkamp B., Wiggers J. K., Allen P. J., et al. Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection. J Am Coll Surg. 2015 Dec; 221 (6): 10419. DOI: 10.1016/j.jamcollsurg.2015.09.005.
2. Jarnagin W. R., Ruo L., Little S. A., et al. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer. 2003 Oct 15; 98 (8): 1689700. DOI: 10.1002/cncr.11699
3. Molina V., Sampson J., Ferrer J., et al. Klatskin tumor: Diagnosis, preoperative evaluation and surgical considerations. Cir Esp. 2015 Nov; 93 (9): 55260. English, Spanish. DOI: 10.1016/j.ciresp.2015.07.003.
4. Soares K. C., Kamel I., Cosgrove D. P., et al. Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobiliary Surg Nutr. 2014 Feb; 3 (1): 1834. DOI: 10.3978/j.issn.2304-3881.2014.02.05.
5. Долгушин Б. И. Внутрипротоковая фотодинамическая терапия при воротной холангиокарциноме у неоперабельных больных / Б. И. Долгушин [и др.] // Анналы хирургической гепатологии. – 2016. – 21 (3): 10618. [Dolgushin B. I., Sergeeva O. N., Frantsev D. Y., et al. Intraductal Photodynamic Therapy of Hilar Cholangiocarcinoma in Inoperable Patients. Annals of Surgical Hepatology. 2016; 21 (3): 106-18. (In Russian)].
6. Францев Д. Ю. Лечение гилюсной холангиокарциномы. Современное состояние вопроса / Д. Ю. Францев, О. Н. Сергеева, Б. И. Долгушин // Сибирский онкологический журнал. – 2019. – 18 (1): 10315. [Frantsev D. Yu., Sergeeva O. N., Dolgushin B. I. Therapy for hilar cholangiocarcinoma. Siberian Journal of Oncology. 2019; 18 (1): 10315. (In Russian)]. URL: https://cyberleninka.ru/article/n/lechenie-gilyusnoy-holangiokartsinomy?ysclid=l8ctpwdtu116474656
7. Tzerkovsky D. A. Multiplefield interstitial photodynamic therapy of subcutaneously transplanted cholangiocellular carcinoma RS1 in rats. Exp Oncol. 2017 Jul; 39 (2): 11720. PMID: 29483499.
8. Wang J. B., Liu L. X., Pan SH, et al. Therapeutic effect of photodynamic therapy using hematoporphyrin monomethyl ether (HMME) on human cholangiocarcinoma cell line QBC939. Neoplasma. 2010; 57 (1): 7985. DOI: 10.4149/neo_2010_01_079.
9. Kim C. H., Chung C. W., Choi K. H., et al. Effect of 5aminolevulinic acidbased photodynamic therapy via reactive oxygen species in human cholangiocarcinoma cells. Int J Nanomedicine. 2011; 6: 135763. DOI: 10.2147/IJN.S21395.
10. Sergeeva O., Frantsev D., Shorikov M., et al. Endobiliary photodynamic therapy in hilar cholangiocarcinoma patients after noncurative liver and bile duct resections: initial results(eposter). The 7 th Asian Congress of Abdominal Radiology and the 20 th Chinese Congress of Abdominal Radiology (ACAR 2019 & CCAR 2019), May 2326, 2019, Chengdu, China.
11. Nanashima A., Yamaguchi H., Shibasaki S., et al. Adjuvant photodynamic therapy for bile duct carcinoma after surgery: a preliminary study. J Gastroenterol. 2004 Nov; 39 (11): 1095101. DOI: 10.1007/s00535-004-1449-z.
12. Wagner A., Wiedmann M., Tannapfel A., et al. Neoadjuvant DownSizing of Hilar Cholangio carcinoma with Photodynamic Therapy — Long Term Outcome of a Phase II Pilot Study. Int J Mol Sci. 2015 Nov 6; 16 (11): 2661928. DOI: 10.3390/ijms161125978.
13. Kasuya K., Oka K., Soya R., et al. Photodynamic therapy for biliary tract organ via a novel ultrasmall composite optical fiberscope. Exp Ther Med. 2017 Nov; 14 (5): 43448. DOI: 10.3892/etm.2017.5052.
Review
For citations:
Frantsev D.Yu., Virshke E.R., Pogrebnyakov I.V., Nasonova E.A., Abdulkarimova S.M., Polyakov A.N., Podluzhny D.V., Kudashkin N.E., Moroz E.A., Timofeev M.E., Dolgushin B.I. Neoadjuvant Endobiliary Photodynamic Therapy in Klatskin Tumor Patients before Resection. First Experience. Journal of oncology: diagnostic radiology and radiotherapy. 2022;5(3):70-77. (In Russ.) https://doi.org/10.37174/2587-7593-2022-5-3-70-77